An object of the present invention is to provide a novel medicament with which motor neuron diseases can be treated. According to the present invention, there is provided a therapeutic agent for motor neuron diseases which comprises 3-methyl-1-phenyl-2-pirazoline-5-on or physiologically acceptable salts thereof as an active ingredient.

 
Web www.patentalert.com

< Radiolabeled neuropeptide Y Y5 receptor antagonists

< Cholesterol lowering supplement

> Combination comprising combretastatin and anticancer agents

> Excipients containing low residual solvent and method for producing the same

~ 00201